Replies to post #238158 on Anavex Life Sciences Corp (AVXL)

[anders2211]

If it is this good for MS, you think BIIB will sit on the drug for 3 years and think about it??

Last 3 years there was hardly any evidence now a little more so yes.

I think they would sit on 273 until there is undeniable evidence and then offer billions rather than now that the paper is published.

Also I think Biogen will not invest in 273 for MS until after they have concluded that their Opicinumab is not working...

[powerwalker]

Pee, no one, who knows what happened w/ the MTA, is talking. For all we know, BIIB decided to wait for Anavex to fail in the AD trial and then come crawling back to deal with it.


ANAVEX NOW ... NOW ... RIGHT NOW!!!